Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: New Intraoperative Nerve Monitoring Device [NA]
A clinical trial update describes a new intraoperative nerve monitoring device being evaluated for use in thyroid cancer and parathyroid ade…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Observational Study on Thyroid Tumors and EvaLuation of the roLe of New pOntential Predictive/Prognostic Factors
This is an observational study on thyroid tumors to evaluate new predictive and prognostic factors. Enrollment is by invitation and the spon…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating a dual-targeting tracer TATE-RGD for imaging SSTR- and RGD-positive tumors. The study targets iod…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of cemiplimab with dabrafenib and trametinib in patients with anaplastic thyroid…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer [Phase 1]
A Phase 1 clinical trial at Johns Hopkins is evaluating a combination of radiotherapy and radiopharmaceutical therapy for recurrent thyroid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating carbon nanoparticle-loaded iron (CNSI-Fe(II)) in patients with advanced solid tumors has completed, with results po…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating APL-101 in non-small cell lung cancer with MET exon 14 skipping mutations and MET dysregulation, as well as other M…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study [EARLY_Phase 1]
Phase 1 pilot study exploring whether adding the BRAF inhibitor vemurafenib can enhance radioiodine uptake in patients with BRAF-mutant, rad…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on Cytology [Phase 2, Phase 3]
A completed phase 2/3 trial evaluating the combination of ultrasonography with Ti-RADS scoring and dual tracer scintigraphy (MIBI Tc-99m and…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer [NA]
A clinical trial update about a PET imaging study using the radiotracer 18F-TFB in patients with thyroid cancer; the study is currently acti…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
This clinical trial update describes a post-market study to evaluate the performance of the Idylla ThyroidPrint assay on clinical samples to…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
A clinical trial from Fujian Medical University is evaluating whether intraoperative neuromuscular monitoring affects acoustic outcomes befo…
-
CLINICAL_TRIALS research · 2025-05-19Clinical Trial Update: Hereditary Risk Factors for Thyroid Cancer [NA]
This entry notes a clinical trial investigating hereditary risk factors for thyroid cancer, sponsored by Dana-Farber Cancer Institute, which…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model
This clinical trial update describes the development of a proteogenomics-based classification and prognosis prediction model for thyroid can…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Brodalumab in the Treatment of Immune-Related Adverse Events [Phase 1]
Phase 1 study of brodalumab for treatment of immune-related adverse events in cancer patients. The trial is currently recruiting across mult…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients. [NA]
Clinical trial update examining the necessity of TSH suppression therapy in active surveillance for thyroid cancer, including papillary thyr…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer [Phase 1]
Phase I trial of biologics plus chemoradiation therapy for advanced head and neck cancer has completed its Phase I portion.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer
A clinical trial comparing safety and efficacy of transoral robotic thyroidectomy versus traditional open thyroidectomy for thyroid cancer i…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node Metastasis
A completed clinical trial update investigates whether a tumor microenvironment collagen signature can predict metastasis to the superior me…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer [NA]
A clinical trial is assessing shared decision-making to guide treatment choices for low-risk thyroid cancer (papillary thyroid carcinoma). T…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Memorial Sloan Kettering Cancer Center is conducting a study to collect information about using redifferentiating medications as standard tr…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
A clinical trial evaluating an 18F-labeled FAP-targeted molecular imaging probe for early tumor diagnosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
A clinical trial update for TOPICS-THYROID, a Taiwanese oncogenetic panel and integrated clinical data registry study. It targets advanced t…